PCTs fight for local decision making on controversial drugs

By Helen Crump2008-08-21T09:00:00

Primary care trusts must retain their right to decide whether patients receive controversial drugs in exceptional circumstances, PCT leaders have warned.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here